Menu
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow4.93 M USD-612186 USD6.09 M USD8.45 M USD6.34 M USD5.42 M USD3.06 M USD3.11 M USD-557714 USD569478 USD5.88 M USD6.69 M USD
Depreciation & Amortization4.15 M USD4.90 M USD4.94 M USD5.33 M USD4.61 M USD4.75 M USD4.40 M USD2.98 M USD2.65 M USD2.40 M USD2.25 M USD1.99 M USD
Stock-Based Compensation408320 USD301895 USD365040 USD447503 USD741867 USD1.05 M USD1.49 M USD1.36 M USD1.12 M USD852102 USD622503 USD761663 USD
Capital Expenditures97903 USD66461 USD281268 USD102148 USD103532 USD140817 USD246202 USD455569 USD275960 USD130872 USD142965 USD163258 USD
Cash Flow from Investing-4.71 M USD57842 USD-105695 USD-13.67 M USD-501893 USD-1.76 M USD2.30 M USD-27.72 M USD9.51 M USD-3.12 M USD-2.34 M USD-6.03 M USD
Cash Flow from Financing-6.75 M USD196904 USD-7.42 M USD-2.06 M USD-3.55 M USD-7.12 M USD-5.08 M USD7.14 M USD1.95 M USD-1.15 M USD-5.19 M USD-1.66 M USD
Dividends Paid
Stock Buybacks263478 USD579049 USD740533 USD1.05 M USD1.39 M USD1.85 M USD3.49 M USD2.88 M USD3.72 M USD2.52 M USD5.34 M USD4.32 M USD
Free Cash Flow4.83 M USD-678647 USD5.81 M USD8.35 M USD6.24 M USD5.27 M USD2.81 M USD2.66 M USD-833674 USD438606 USD5.73 M USD6.53 M USD

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of innovative prescription products aimed at improving patient care. The company primarily operates in the healthcare sector, offering a portfolio of niche-market prescription products that address significant medical needs. Cumberland's product range includes treatments for hospital acute care settings, gastroenterology, and oncology, catering to specific therapeutic segments. Founded in 1999 and headquartered in Nashville, Tennessee, the company leverages a network of direct salesforce alongside partnerships with other health care providers and distributors to ensure broad product availability across the United States market. Cumberland Pharmaceuticals plays a critical role in the healthcare industry by providing essential medications that enhance treatment outcomes and address unmet medical needs. Its commitment to expanding therapeutic options and improving patient access to specialized treatments underscores its significance in the pharmaceutical market.